Approval · Notice of Compliance 21145 · 2018
ALUNBRIG: Notice of Compliance 21145
Issued July 26, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21145
- Date
- July 26, 2018
- Company
- Takeda Canada IncorporatedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
Medicinal ingredients
- BRIGATINIB 30 MG per TAB
- BRIGATINIB 90 MG per TAB
- BRIGATINIB 180 MG per TAB